Cardiac manifestations of pheochromocytoma;Manifestations cardiaques des phéochromocytomes

Annales d'Endocrinologie

Volumn 70, Issue 1, 2009, Pages 43-47

  Luca, F ^a   Holl, N ^a   Vinzio, S ^a   Grunenberger, F ^a   Suna, C ^a   Taquet, M C ^a   Goichot, B ^a   Schlienger, J L ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Arrythmia; Cardiogenic shock; Dilated cardiomyopathy; Pheochromocytoma

Indexed keywords

CATECHOLAMINE; VASOACTIVE AGENT;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CATECHOLAMINE BLOOD LEVEL; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSKINESIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PHEOCHROMOCYTOMA; REVIEW; TAKOTSUBO CARDIOMYOPATHY; VITAMIN SUPPLEMENTATION;

ACUTE CORONARY SYNDROME; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; HUMANS; PHEOCHROMOCYTOMA; SHOCK, CARDIOGENIC;

EID: 61349127146     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2008.11.002     Document Type: Review

References (46)

1. Plouin P.F., Gimenez-Roqueflo A.P., Batide Alanore A., Salenave S., and Duclos J.M. Progrès récents dans le diagnostic, l'évaluation pronostique et le traitement des phéochromocytomes. Rev Med Interne 21 (2000) 1075-1085
2. Sutton M.G., Sheps S.G., and Lie J.T. Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clinic Proc 56 (1981) 354-359
3. Plouin P.F., Degoulet P., Tugaye A., Ducrocq M.B., and Menard J. Dépistage du phéochromocytome : chez quels hypertendus ? Étude sémiologique chez 2585 hypertendus dont 11 ayant un phéochromocytome. Nouv Presse Med 10 (1981) 869-872
4. Bravo E.L., and Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocrine Rev 24 (2003) 539-553
5. Salathe M., Weiss P., and Ritz R. Rapid reversal of heart failure in a patient with pheochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J 68 (1992) 527-528
6. Schifferdecker B., Kodali D., et al. Adrenergic shock - an overlooked clinical entity?. Cardiol Rev 13 (2005) 69-72
7. Sibal L., Jovanovic A., Agarwal S.C., Peaston R.T., Perros P., et al. Pheochromocytomas presenting as acute crisis after beta blockade therapy. Clin Endocrinol 65 (2006) 186-190
8. Kizer J.R., Koniaris L.S., Edelman J., and Sutton S.J. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest 118 (2000) 1221-1223
9. Brouwers F.M., Lenders J., Eisenhofer G., and Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 4 (2003) 121-128
10. Tournoux F., Bal L., Hamoudi N., Desmonts J.M., and Steg P.G. Syndromes coronariens aigus et phéochromocytome. Ann Cardiol Angeiol (Paris) 53 (2004) 273-275
11. Darzé E.S., and Von Sohsten R.L. Pheochromocytoma-induced segmental myocardial dysfunction mimicking an acute myocardial infarction in a patient with normal coronary arteries. Arq Bras Cardiol 82 (2004) 178-180
12. Zweiker R., Tiemann M., Eber B., Schumacher M., Fruhwald F.M., Klein W., et al. Bradydysrhythmia-related presyncope secondary to pheochromocytoma. J Intern Med 242 (1997) 249-253
13. Pachalis-Purtak K., Pucitowska B., Prejbisz A., and Januszewicz A. Cardiac arrests, atrioventricular block, and pheochromocytoma. Am J Hypertens 17 (2004) 544-545
14. Roshan J., George O.K., Vineet S., George P.V., and Jose V.j. Torsade de pointes in a case of pheochromocytoma - an unusual presentation of an uncommon disease. Indian Heart J 56 (2004) 248-249
15. Lagable M., Perol M., Guerin J.C., and Milon H. Myocardite adrénergique, une cardiomyopathie potentiellement curable. Presse Med 20 (1991) 1137
16. Wittstein I.S., Thiemann D.R., Lima J., Baughman K., Champion H.C., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352 (2005) 539-548
17. Roux X., Chevalier J.M., Laplace G., Brandstatt P., Bire F., and Massoure P.L. Syndrome de ballonisation apicale transitoire du ventricule gauche. Revue de la littérature à propos d'un cas. Rev Med Interne 27 (2006) 776-782
18. Mardelle V., Ramiara P., Xeridat F., and Peytel E. Syndrome de tako-tsubo : à propos d'une observation. Ann Fr Anesth Reanim 26 (2007) 181-182
19. Takizawa M., Kobayakawa N., Uozumi H., Yonemura S., Aoyagi T., et al. A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy. Int J Cardiol 114 (2007) E15-E17
20. Virani S., Khan N., Mendosa C., Ferreira A., and de Marchena E. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J 34 (2007) 76-79
21. Tsuchihashi K., Ueshima K., Ushida T., Oh-mura N., Kimura K., and Owa M. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 38 (2001) 11-18
22. Desmet W.J.R., Adriaenssens B.F.M., and Dens J.A.Y. Apical ballooning of the left ventricle: first series in white patients. Heart 89 (2003) 1027-1031
23. Lipiecki J., Durel N., Decalf V., Soubeyrand P., Moisa A., and Citron B. Transient left ventricular apical ballooning or the tako-tsubo syndrome. Arch Mal Coeur Vaiss 98 (2005) 275-280
24. Kurisu S., Sato H., Kawagoe T., Ishihara M., Shimatani Y., and Nisshioka K. Tako-tsubo like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 143 (2002) 448-455
25. Kanjaa N., Khatouf M., Elhijri A., Harrandou M., Azzouzi A., Benerradi H., et al. Phéochromocytomes. Formes graves et inhabituelles. Ann Fr Anesth Reanim 17 (1999) 458-464
26. Ouchikhe A., Lehoux P., Gringore A., Renouf P., Deredec R., Gerard J.L., et al. Le phéochromocytome comme cause inhabituelle de choc cardiogénique. Ann Fr Anesth Reanim 25 (2006) 46-49
27. Baratella M.C., Menti L., Angelini A., and Daliento L. An unusual case of myocarditis. Int J Cardiol 65 (1998) 305-310
28. Bergland B.E. Pheochromocytoma presenting as shock. Am J Emerg Med. 7 (1989) 44-48
29. Chardigny C., Bensasson D., Couetil J.P., Abastado P., and Cousin M.T. Cardiac failure caused by cardiomyopathy disclosing pheochromocytoma. Perioperative treatement. Ann Cardiol Angeiol (Paris) 43 (1994) 17-21
30. Dalby M.C.D., Burke M., Radley-Smith R., and Banner N.R. Pheochromocytoma presenting after cardiac transplantation for dilated cardiomyopathy. J Heart Lung Transplant 20 (2001) 773-775
31. Kurisu S., Inoue I., Kawagoe T., Ishihara M., Shimatani Y., and Nakamura S. Time course of electrocardiographic changes in patients with takotsubo syndrome: comparison with acute myocardial infarction with minimal enzymatic release. Circ J 68 (2004) 77-81
32. Mootha V.K., Feldman J., Mannting F., Winters G., and Johnson W. Pheochromocytoma-induced cardiomyopathy. Circulation 102 (2000) e11-e13
33. Schiano P, Revel F, Barbou F, Guiraudet O, Lerecouvreux M, Monsegu J. Toxicité myocardique des catécholamines : à propos de deux observations. Rev Med Int 2007;28:866-70.
34. Marboeuf P., Ennezat P.V., Gonin X., Aubert J.M., Auffray J.L., Bauchart J.J., et al. Tako tsubo syndrome and left ventricular obstruction: mechanism?. Arch Mal Coeur Vaiss 99 (2006) 69-72
35. Aubert J.M., Ennezat P.V., Tricot O., Darchis J., Bauchart J.J., and Auffray J.L. Mid-ventricular balooning heart syndrome. Echocardiography 24 (2007) 329-334
36. Sanchez-Recalde A., Costero O., Olivier J.M., Iborra C., Ruiz E., and Sobrino J.A. Pheochromocytoma-related cardiomyopathy. Circulation 113 (2006) e738-e739
37. Dorn Gerald W. Adrenergic pathways and left ventricular remodelling. J Card Fail 8 (2002) S370-S373
38. Akashi Y.J., Sakakibara M., and Miyake F. Reversible left ventricular dysfunction "takotsubo" cardiomyopathy associated with pneumothorax. Heart 87 (2002) E1
39. Bybee K.A., Prasad A., Barsness G.W., et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol 94 (2004) 343-346
40. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 (1999) 609-634
41. Lin P.C., Hsu J.T., Chung C.M., and Chang S.T. Pheochromocytoma underlying hypertension, stroke and dilated cardiomyopathy. Tex Heart Inst J 34 (2007) 244-246
42. Behonick G.S., Novak M.J., Nealley E.W., and Baskin S.I. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J Appl Toxicol 21 Suppl. 1 (2001) S15-22
43. Singal P.K., Kapur N., Dhillon K.S., et al. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 60 (1982) 1390-1397
44. Aragona M., and Aragona F. Pheochromocytoma and catecholamine cardiomyopathy. Pathologica 84 (1992) 197-203
45. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
46. Lebuffe G., Dosseh E.D., Tek G., Tytgath H., Moreno S., Tavernier B., et al. The effect of calcium channel blockers on outcome following the surgical treatment of pheochromocytomas and paragangliomas. Anesthesia 60 (2005) 439-444